|
Volumn 24, Issue 3, 2001, Pages 180-205
|
Guidelines for the management of intravascular catheter-related infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMPHOTERICIN B;
AMPICILLIN;
AZTREONAM;
CARBAPENEM;
CEFAZOLIN;
CEFEPIME;
CEFTRIAXONE;
CEFUROXIME;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
FLUCONAZOLE;
GENTAMICIN;
IMIPENEM;
LEVOFLOXACIN;
LINEZOLID;
MEROPENEM;
METICILLIN;
MEZLOCILLIN;
NAFCILLIN;
OXACILLIN;
PENICILLIN G;
PIPERACILLIN;
RIFAMPICIN;
SULTAMICILLIN;
TICARCILLIN;
TIMENTIN;
UNINDEXED DRUG;
VANCOMYCIN;
ANTIBIOTIC THERAPY;
BLOOD CULTURE;
CANDIDA ALBICANS;
CATHETER INFECTION;
CENTRAL VENOUS CATHETER;
CENTRAL VENOUS CATHETERIZATION;
CLINICAL EXAMINATION;
COAGULASE NEGATIVE STAPHYLOCOCCUS;
HEMODIALYSIS;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
PRACTICE GUIDELINE;
REVIEW;
RISK MANAGEMENT;
STAPHYLOCOCCUS AUREUS;
TREATMENT PLANNING;
ANTI-INFECTIVE AGENTS;
BACTEREMIA;
CATHETERIZATION, CENTRAL VENOUS;
CATHETERIZATION, PERIPHERAL;
CATHETERS, INDWELLING;
CROSS INFECTION;
EQUIPMENT CONTAMINATION;
EVIDENCE-BASED MEDICINE;
FUNGEMIA;
HUMANS;
|
EID: 0035017904
PISSN: 08965846
EISSN: None
Source Type: Journal
DOI: 10.1086/320001 Document Type: Review |
Times cited : (134)
|
References (0)
|